Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F08398)

Formulation Name

Flucytosine 250 mg capsule

Company

Oceanside Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Flucytosine	DM13VTW	Endocarditis	BB40-BA42	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	E00099	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Butylparaben	E00142	7184	Antimicrobial preservative
FD&C blue no. 1	E00263	19700	Colorant
Ferrosoferric oxide	E00231	14789	Colorant
methylparaben	E00149	7456	Antimicrobial preservative
Propyl 4-hydroxybenzoate	E00141	7175	Antimicrobial preservative
Quinoline yellow WS	E00309	24671	Colorant
Sodium propionate	E00445	2723816	Antimicrobial preservative
Sunset yellow FCF	E00255	17730	Colorant
Talc	E00520	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	E00322	26042	Coating agent; Colorant; Opacifying agent

--------------------